Steven Holtzman - Co-Founder @ Shoreline Biosciences - Crunchbase Person Profile

Start Free Trial

Overview

Number of Portfolio Companies

Number of Exits

Unlock for free

Primary Job Title Co-Founder
Primary Organization
Shoreline Biosciences

Location Center Harbor, New Hampshire, United States
Regions East Coast, New England, Northeastern US
Gender Male

Investor Type
obfuscated
obfuscation
Number of Exits
obfuscated
obfuscation

LinkedIn View on LinkedIn

Steven Holtzman is a Co-Founder and board member of Shoreline Biosciences.

Personal Investments

Number of Investments

Steven Holtzman

invested in

Infinity Pharmaceuticals

on

obfuscation

. This investment -

Series B - Infinity Pharmaceuticals

- was valued at

obfuscation

.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Infinity Pharmaceuticals	—	Series B - Infinity Pharmaceuticals	obfuscated obfuscation

Exits

Number of Exits

Unlock for free

Steven Holtzman

has

obfuscation

exit -

Infinity Pharmaceuticals

.

Steven Holtzman

has

obfuscation

exits. Their most notable exits are

Infinity Pharmaceuticals

.

Infinity Pharmaceuticals Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.

Jobs

Number of Current Jobs

Steven Holtzman

is the

Co-Founder

at

Shoreline Biosciences

.

Shoreline Biosciences Co-Founder

Board and Advisor Roles

Number of Current Board & Advisor Roles

Steven Holtzman

is the

Board Member

at

Shoreline Biosciences

.

Shoreline Biosciences Board Member

Related Hubs

Hub Name	CB Rank (Hub)
Eventide Portfolio Companies	56,925
Medical Early Stage Companies With More Than 50 Employees	53,329
Life Science Early Stage Companies With Fewer Than 1000 Employees	42,582
Medical Early Stage Companies With Fewer Than 1000 Employees	29,925
Ally Bridge Group Portfolio Companies	78,085
Cormorant Asset Management Portfolio Companies	77,366
Life Science Early Stage Companies With Fewer Than 100 Employees	44,274
Life Science Companies with Early Stage Venture Funding	40,484
Boxer Capital Portfolio Companies	89,976
Biotechnology Early Stage Companies With More Than 50 Employees	49,832

Recent News and Activity

Funding Round•

Jun 24, 2002

Infinity Pharmaceuticals raised

obfuscation

from Advent Life Sciences and 11 other investors

Discover more funding rounds